secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-09-04T20:05:22+00:00
Accession:  0001493152-26-041537
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 1.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech converts $1.22M promissory note into 5.07M shares, note satisfied
--------------------------------------------------------------------------------

- Converted ~$1,224,341 of Feb 16, 2024 promissory note into 5,065,840 shares at avg $0.24/share.
- Promissory note (original principal $3,301,250) fully satisfied as of Sept 3, 2026; no amounts owing.
- Exchange shares issued under Section 3(a)(9) exemption; no commission or remuneration paid.
- Stockholders approved conversion at July 15, 2026 special meeting per NYSE American rules.
- Shares to be free-trading under Rule 144; holding period tacks to Feb 16, 2024 original note date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226041537/0001493152-26-041537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226041537/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer